LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.49 | 27.76 | 1415 | 1723 | 0.8212 | 0.9349 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.19 | 27.76 | 1185 | 1863 | 0.6360 | 0.8563 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.19 | 27.76 | 1260 | 1863 | 0.6763 | 0.8752 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.19 | 27.76 | 1509 | 1863 | 0.8099 | 0.9317 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.19 | 27.76 | 1541 | 1863 | 0.8271 | 0.9384 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.90 | 27.76 | 1259 | 2032 | 0.6195 | 0.8512 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.90 | 27.76 | 1318 | 2032 | 0.6485 | 0.8649 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.90 | 27.76 | 1501 | 2032 | 0.7386 | 0.9045 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.90 | 27.76 | 1539 | 2032 | 0.7573 | 0.9122 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.60 | 27.76 | 1319 | 2235 | 0.5899 | 0.8401 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.60 | 27.76 | 1385 | 2235 | 0.6195 | 0.8543 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.60 | 27.76 | 1644 | 2235 | 0.7353 | 0.9052 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 32.60 | 27.76 | 1673 | 2235 | 0.7483 | 0.9105 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.30 | 27.76 | 1397 | 2449 | 0.5703 | 0.8335 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.30 | 27.76 | 1449 | 2449 | 0.5915 | 0.8439 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.30 | 27.76 | 1724 | 2449 | 0.7037 | 0.8942 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.30 | 27.76 | 1750 | 2449 | 0.7144 | 0.8986 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.01 | 27.76 | 1469 | 2662 | 0.5517 | 0.8272 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.01 | 27.76 | 1515 | 2662 | 0.5689 | 0.8358 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.01 | 27.76 | 1729 | 2662 | 0.6493 | 0.8730 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.01 | 27.76 | 1754 | 2662 | 0.6587 | 0.8771 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.71 | 27.76 | 1552 | 2877 | 0.5393 | 0.8238 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.71 | 27.76 | 1602 | 2877 | 0.5567 | 0.8325 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.71 | 27.76 | 1889 | 2877 | 0.6564 | 0.8781 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 37.71 | 27.76 | 1918 | 2877 | 0.6665 | 0.8824 | MN20160318_Q01 | M06 |